−0.0480SEK
−11.11 MSEK
About APTAHEM AB
Sector
CEO
Knut Mikael Ingolf Lindstam
Headquarters
Malmö
Website
Employees (FY)
9
Founded
2014
ISIN
SE0006543450
FIGI
BBG008GSTLB3
Aptahem AB operates as a biotechnology company. The firm engages in developing drug candidates for the treatment and prevention of disease caused by blockages in blood vessels as the result of blood clots, such as deep vein thrombosis, stroke and heart failure. Its main business model is to clinically develop aptamer-based treatments for life-threatening acute conditions where coagulation and inflammation interact in the disease process. The company was founded byLuiza Jedlina, Bert Junno, Tina Persson and Johan Lindh in 2014 and is headquartered in Malmo, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of APTA is 0.04 SEK — it has increased by 2.00% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NGM exchange APTAHEM AB stocks are traded under the ticker APTA.
Yes, you can track APTAHEM AB financials in yearly and quarterly reports right on TradingView.
Like other stocks, APTA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade APTAHEM AB stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 9.00 employees. See our rating of the largest employees — is APTAHEM AB on this list?